Primex Pharmaceuticals and POA Pharma sign a strategic partnership to commercialise OZALIN in the Nordic region.
Gothenberg and Zug, 21st February 2019 – POA Pharma Scandinavia AB, a market-oriented Boutique Healthcare Company, working in close contact